• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • VERAXA and Quadira Enter ADC Development Partnership contractpharma
    June 16, 2021
    ​VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), an ADC engineering and functional antibody screening company, has entered into a partnership with Quadira Biosciences AG of Zug, Switzerland, to develop a suite of novel ADCs for the treatment of ...
  • VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development b3cnewswire
    June 15, 2021
    VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), announced today that it has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland， to jointly develop a suite of novel ADCs for the treatment of oncological conditions.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service